The two device giants and five other companies are accused of promoting the off-label use of microwave cardiac ablation products and of bilking the Medicare system in a federal whistleblower lawsuit.
Boston Scientific Corp.'s notorious acquisition of Guidant Corp. is causing even more headaches for the Natick-based devices giant, now that a federal "qui tam" whistleblower lawsuit accuses the pair (and five other medical device makers including Medtronic Inc.) of promoting the off-label use of microwave cardiac ablation and potentially bilking millions from the Medicare system.
Transcatheter aortic valve implantation proves successful in reinforcing failed valve prosthetics,...
A rare but deadly genetic mutation that prevents the body from absorbing protein can be set off by...
Ohio-based medical device makers meet with local legislators to discuss efforts to repeal the...
Boston Scientific's Lotus TAVI system minimizes leakage in an early trial, St. Jude Medical gains on...
Electromed founder, chairman & CEO Robert Hansen announces his retirement after 20 years leading...